Bayer Agrees to Halt Ads for Aleve

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Bayer Healthcare has agreed to stop all advertising for its over-the-counter analgesic Aleve that carries the tagline “Prescription strength relief without a prescription.”

The decision came following a recommendation by the National Advertising Division (NAD) of the Council of Better Business Bureaus. The NAD had reviewed the ads after a complaint was brought by rival Wyeth Consumer Healthcare.

Bayer spent $55 million on ads for Aleve last year, per Nielsen Monitor-Plus. Omnicom Group’s BBDO in Chicago is the brand’s lead agency.

“Bayer





AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in